Publication
Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
Innocent Valéa, Innocent Valéa, Samuel Adjei, Samuel Adjei, Effua Usuf, Effua Usuf, Ousmane Traore, Ousmane Traore, Daniel Ansong, Daniel Ansong, Halidou Tinto, Halidou Tinto, Harry Owusu Boateng, Harry Owusu Boateng, Amanda Leach, Amanda Leach, Athanase Mwinessobaonfou Some, Athanase Mwinessobaonfou Some, Patrick Buabeng, Patrick Buabeng, Johan Vekemans, Johan Vekemans, Louis Arnaud Nana, Louis Arnaud Nana, Amos Kotey, Amos Kotey, Pascale Vandoolaeghe, Pascale Vandoolaeghe, Florence Ouedraogo, Florence Ouedraogo, David Sambian, David Sambian, Marc Lievens, Marc Lievens, Marc Christian Tahita, Marc Christian Tahita, Theresa Rettig, Theresa Rettig, Erik Jongert, Erik Jongert, Palpouguini Lompo, Palpouguini Lompo, Ali Idriss, Ali Idriss, Dorota Borys, Dorota Borys, Sayouba Ouedraogo, Sayouba Ouedraogo, Frank Prempeh, Frank Prempeh, Md Ahsan Habib, Md Ahsan Habib, Lode Schuerman, Lode Schuerman, Hermann Sorgho, Hermann Sorgho, Tsiri Agbenyega, Tsiri Agbenyega
Human Vaccines & Immunotherapeutics, April 2018, Taylor & Francis
DOI: 10.1080/21645515.2018.1442996